Atlas Trials

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Clinical trial NCT00790842 · TERMINATED

Trial details

NCT number
NCT00790842
Sponsor
PrECOG, LLC.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaPlasma Cell Neoplasm
Start date
2009-01-21
Primary completion
2017-09-30
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.